head and neck cancer

ImmunoGen Offers New Hope For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Cancers

ImmunoGen Offers New Hope For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Cancers

Seeking Alpha

Submitted by moderatorj on Thu, 09/20/2012 - 22:43

Pilot Study in Patients with Head and Neck Cancer Finds That Derma Sciences’ MEDIHONEY® Reduces Hospital Stays in the U.K.

Pilot Study in Patients with Head and Neck Cancer Finds That Derma Sciences’ MEDIHONEY® Reduces Hospital Stays in the U.K.

Yahoo/BusinessWire

Oncolytics expands enrollment for cancer drug late-stage trial

Oncolytics expands enrollment for cancer drug late-stage trial

Reuters

Cel-Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug

Cel-Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug

Seeking Alpha

SciClone Pharmaceuticals halts mid-stage study of potential drug due to poor results

SciClone Pharmaceuticals halts mid-stage study of potential drug due to poor results

Yahoo/AP

CEL-SCI says Multikine Phase III trial launched in dozens of hospitals

CEL-SCI says Multikine Phase III trial launched in dozens of hospitals

The Fly on the Wall

CEL-SCI Corporation Releases Letter to Shareholders

CEL-SCI Corporation Releases Letter to Shareholders

Yahoo/BusinessWire

Bristol-Myers Approved to Market Erbitux for Wider Cancer Use

Bristol-Myers Approved to Market Erbitux for Wider Cancer Use

Bloomberg

CEL-SCI gets Israeli nod to commence phase III trial of multikine in head and neck cancer

CEL-SCI gets Israeli nod to commence phase III trial of multikine in head and neck cancer

pharmabiz